Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●World Health Organization (WHO): Abortion care guideline (2022)
●WHO: Family Planning – A Global Handbook for Providers, 4th edition (2022)
●WHO: Guideline on self-care interventions for health and well-being, revision (2022)
●WHO: Guideline on medical eligibility criteria for contraceptive use, 5th edition (2015)
Canada
●SOGC: Committee opinion on coercion free contraceptive care (2021)
●SOGC: Clinical practice guideline on menstrual suppression in special circumstances (2014, reaffirmed 2019)
●Canadian Paediatric Society (CPS): Position statement on contraceptive care for Canadian youth (2018)
●SOGC: Canadian contraception consensus – Combined hormonal contraception (2017)
•SOGC: Canadian contraception consensus – Emergency contraception (2015)
●SOGC: Canadian contraception consensus – Intrauterine contraception (2016)
●SOGC: Canadian contraception consensus – Progestin-only contraception (2016)
●SOGC: Canadian contraception consensus – Barrier methods (2015)
●SOGC: Canadian contraception consensus – Contraception in Canada (2015)
●SOGC: Canadian contraception consensus – Contraceptive care and access (2015)
●SOGC: Canadian contraception consensus – Natural family planning (2015)
●SOGC: Canadian contraception consensus – Permanent contraception (2015)
United States
●Society of Family Planning (SFP): Clinical guidance
●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on comprehensive sexuality education (2016, reaffirmed 2023)
●ACOG: Committee opinion on depot medroxyprogesterone acetate and bone effects (2014, reaffirmed 2023)
●ACOG: Committee statement on improving access to intrauterine devices and contraceptive implants (2023)
●ACOG: Clinical consensus on general approaches to medical management of menstrual suppression (2022)
●ACOG: Committee opinion on access to contraception (2015, reaffirmed 2022)
●ACOG: Committee statement on patient-centered contraceptive counseling (2022)
●ACOG: Practice advisory on hormonal contraception and risk of breast cancer (2018, reaffirmed 2022)
●US Food and Drug Administration (FDA): Essure permanent birth control (updated 2022)
●Women's Preventive Services Initiative (WPSI): Clinical recommendations on contraception (2016, updated 2022)
●American Academy of Pediatrics (AAP): Clinical report on contraception for HIV-infected adolescents (2016, reaffirmed 2021)
●AAP: Policy statement on contraception for adolescents (2014, reaffirmed 2021)
●ACOG: Committee opinion on access to postabortion contraception (2021)
●ACOG: Committee opinion on access to postpartum sterilization (2021)
●ACOG: Committee opinion on adolescents and long-acting reversible contraception – Implants and intrauterine devices (2018, reaffirmed 2021)
●ACOG: Committee opinion on counseling adolescents about contraception (2017, reaffirmed 2021)
●ACOG: Committee opinion on health care for transgender and gender diverse individuals (2021)
●ACOG: Committee opinion on optimizing postpartum care (2018, reaffirmed 2021)
●ACOG: Committee opinion on over-the-counter access to hormonal contraception (2019, reaffirmed 2021)
●ACOG: Practice bulletin on long-acting reversible contraception – Implants and intrauterine devices (2017, reaffirmed 2021)
●ACOG and Society for Maternal-Fetal Medicine (SMFM): Obstetric care consensus on interpregnancy care (2019, reaffirmed 2021)
•CDC: US selected practice recommendations for contraceptive use (2016)
●AAP: Clinical report on long-acting reversible contraception – Specific issues for adolescents (2020)
●AAP: Policy statement on barrier protection use by adolescents during sexual activity (2020)
●ACOG: Committee opinion on clinical challenges of long-acting reversible contraceptive methods (2016, reaffirmed 2020)
●ACOG: Committee opinion on sterilization of women – Ethical issues and considerations (2017, reaffirmed 2020)
•CDC: US medical eligibility criteria for contraceptive use (2016)
●AAP: Policy statement on emergency contraception (2019)
●ACOG: Practice bulletin on the benefits and risks of sterilization (2019)
●CDC: Recommendations for providing quality family planning services, 2015 update (published 2016)
•CDC: Recommendations for providing quality family planning services (2014)
United Kingdom
●Faculty of Sexual & Reproductive Healthcare (FSRH): Standards & guidance
●National Institute for Health and Care Excellence (NICE): Clinical guideline on long-acting reversible contraception (2005, updated 2019)
●NICE: Quality standard on contraception (2016)
●RCOG: Consent advice on female sterilisation (2016)
●NICE: Public health guideline on contraceptive services for under 25s (2014)
Australia-New Zealand
●RANZCOG: Statement on emergency contraception (2019)
●RANZCOG: Best practice statement on depot medroxyprogesterone acetate (2018)
●RANZCOG: Clinical guidance on intrauterine contraception (2017)
●RANZCOG: Statement on long acting reversible contraception (2017)
Japan
●[In Japanese] Japan Society of Obstetrics and Gynecology (JSOG): Obstetrics and gynecology clinical practice guidelines – Gynecology outpatient edition (2023)
●[In Japanese] JSOG: OC/LEP – Low-dose oral contraceptives, low-dose estrogen/progestin guideline, 2020 (published 2021)
●[In English] JSOG and Japan Association of Obstetricians and Gynecologists (JAOG): Guideline for gynecological practice in Japan, 2020 edition (published 2021)
●[In Japanese] JSOG: Guidelines for proper use of emergency contraception (2016)
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟